Centric Health Corp. (TSE:CRX – Free Report) – Equities research analysts at Bloom Burton lowered their Q4 2024 earnings estimates for shares of Centric Health in a report issued on Monday, November 11th. Bloom Burton analyst D. Martin now anticipates that the company will post earnings per share of $0.00 for the quarter, down from their prior estimate of $0.02. Bloom Burton also issued estimates for Centric Health’s FY2025 earnings at $0.09 EPS and FY2026 earnings at $0.20 EPS.
CRX has been the topic of several other research reports. Stifel Canada downgraded Centric Health from a “strong-buy” rating to a “hold” rating in a report on Monday, August 12th. Ventum Cap Mkts upgraded shares of Centric Health to a “strong-buy” rating in a research note on Thursday, August 8th.
Centric Health Price Performance
Further Reading
- Five stocks we like better than Centric Health
- What Are the U.K. Market Holidays? How to Invest and Trade
- Rocket Lab is the Right Stock for the Right Time
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Bank Stocks – Best Bank Stocks to Invest In
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
